OPX Biotechnologies
Latest round
- Series D
Last raised
- Jun 2011
Total raised
- $58M
Investors
- 6
About OPX Biotechnologies
OPX Biotechnologies, Inc.Founded in 2007 in Boulder, US, OPX Biotechnologies, Inc. focuses on the production of bio-based chemicals and materials. The company has undergone strategic pivots to enhance its product offerings. In April 2015, it was acquired by Cargill for an undisclosed amount.OPX Biotechnologies, Inc. offers a range of bio-based products and solutions designed to replace petroleum-based chemicals, contributing to sustainability in the chemical industry.OPX Biotechnologies generates revenue through partnerships with Cargill and other businesses in the agricultural sector, focusing on the production of bio-based chemicals. The company aims to expand into new geographic markets, particularly in North America and Europe, by 2017. The acquisition by Cargill in 2015 provides additional resources and alignment with Cargill's extensive distribution networks, facilitating a broader reach for OPX's innovative offerings.
Who invested in OPX Biotechnologies
6 investors across 3 rounds
See all investors in OPX Biotechnologies
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about OPX Biotechnologies
Who invested in OPX Biotechnologies?
OPX Biotechnologies has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has OPX Biotechnologies raised?
OPX Biotechnologies has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did OPX Biotechnologies last raise money?
OPX Biotechnologies's most recent round on record is a Series D, in Jun 2011.
What does OPX Biotechnologies do?
OPX Biotechnologies is a chemicals company.
Where is OPX Biotechnologies headquartered?
OPX Biotechnologies is headquartered in Boulder, US.
Which VCs invest in companies like OPX Biotechnologies?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back chemicals companies at OPX Biotechnologies's stage. Their profiles are linked below.
VCs backing chemicals startups at Series D
Raising like OPX Biotechnologies? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.